Acquired
Novo Nordisk (Ozempic)
David Rosenthal
It does a billion dollars in revenue, but like it's massively supply constrained. Like it could have done a lot more. These drugs still, Ozempic and Wegabee, could do a lot more revenue than they are doing right now.
0
💬
0
Comments
Log in to comment.
There are no comments yet.